Time to re-evaluate the risks and benefits of valproate and a call for action. (2022)
Attributed to:
MICA: Targeting neuro-inflammation in Schizophrenia
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1192/bjp.2022.94
PubMed Identifier: 35795925
Publication URI: http://europepmc.org/abstract/MED/35795925
Type: Journal Article/Review
Volume: 221
Parent Publication: The British journal of psychiatry : the journal of mental science
Issue: 6
ISSN: 0007-1250